On Aug. 11, Morgan Stanley published a report on the impact of anti-obesity drugs on producers of junk food. The analysts, who have estimated the anti-obesity drug market at $54 billion for the year 2030, write about how declining appetites will reduce demand for food, with junk food taking the biggest hit.
Drugs like Wegovy and Ozempic—which cost around $1,000 a month—induce a significant reduction of daily caloric intake: some 20-30%. Based on their estimates of the number of Americans who might take such drugs, Morgan Stanley says that overall calorie consumption will be down 1.7%. But not all foods are created equal! While 46% of people using the drugs reported eating more fruits and vegetables, over 60% of patients reported consuming fewer confections, sugary drinks, baked goods, and salty snacks. Among those using the medications, 77% reported going less often to fast food joints.
